Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Canopy Growth Corp

NASDAQ: CGC · Life Sciences · 6 alerts · CIK 1737927

Share price
$0.5460Close, Nov 16
Market cap
$231M
Shares outstanding
423.35MLatest SEC cover page
Sector
Life Sciences
Industry
Medicinal Chemicals & Botanical ProductsSIC 2833

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Canopy Growth Corp filings on SEC EDGAR ↗

7:07 AM ET 8-K
Financial Results

Canopy Growth Financial Results

Canopy Growth reported Q2 FY2027 consolidated net revenue of $81.4M, a 22% year-over-year increase driven by 141% growth in international markets. The company saw strong performance in its cannabis segment, particularly in Germany and Poland, and is targeting positive adjusted EBITDA during fiscal 2027.

Term
Q2 2027

“We have made tremendous progress on our international strategy. Our international business delivered 141% net revenue growth in the second quarter of fiscal year 2027 driven by strong medical cannabis sales in Germany and Poland.”

Luc Mongeau, Chief Executive Officer

“We reported another quarter of strong net revenue growth, including a 17% year-over-year increase in Canada adult-use cannabis, an 18% increase in Canada medical cannabis and 30% growth in the Cannabis segment overall. We are progressing steadily to profitability, quarter after quarter.”

Tom Stewart, Chief Financial Officer
5:20 PM ET 8-K
Reverse Stock Split

Canopy Growth Reverse Stock Split

Canopy Growth shareholders approved a special resolution at the 2026 Annual General and Special Meeting to authorize a reverse stock split. The Board has the discretion to consolidate common and exchangeable shares at a ratio between 1-for-5 and 1-for-15 at any time prior to September 25, 2027.

5:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Canopy Growth Nasdaq/NYSE Compliance Notice

Canopy Growth Corporation received a deficiency notice from Nasdaq on October 14, 2026, because its common shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Canopy Growth is currently seeking shareholder approval for a potential reverse stock split at its upcoming annual meeting to address the deficiency.

Counterparty
Nasdaq
Term
180 days
4:32 PM ET Form 4
Insider Selling

Canopy Growth Insider Theresa Yanofsky Sells $13.8K of Stock

Theresa Yanofsky sold 14,920 shares of Canopy Growth Corp at $0.9268 a share, worth $13.8K in total on Sep 28, 2026. Shares held after the trade: 131,495 (-10.2%).

Value
$13.8K
Shares
14,920
Price
$0.9268
Holding change
-10.2%
Trade date
Sep 28, 2026
4:31 PM ET Form 4
Insider Selling

Canopy Growth Insider David Angelo Lazzarato Sells $20.7K of Stock

David Angelo Lazzarato sold 22,380 shares of Canopy Growth Corp at $0.9268 a share, worth $20.7K in total on Sep 28, 2026. Shares held after the trade: 189,479 (-10.6%).

Value
$20.7K
Shares
22,380
Price
$0.9268
Holding change
-10.6%
Trade date
Sep 28, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.